
Danish company 21st.BIO has filed an EU Novel Food application for BLG Essential+, a precision-fermented nature-identical bovine beta-lactoglobulin, the main whey protein. The company says approval could ease whey protein supply constraints in Europe, and it is calling for a streamlined EU pathway for precision fermentation.
If EFSA approves the product, it could add non-dairy-cow whey protein supply in Europe, which would ease tight whey prices over time. Approval is still years away, so the near-term price impact is minimal.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.